Back
Permian Resources Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Buy
66
PR
Permian Resources
Last Price:
$15.48
Seasonality Move:
8.16%
Sell
1
CRNX
Crinetics Pharmaceuticals
Last Price:
$35.54
Seasonality Move:
-6.74%
Buy
66
Permian Resources (PR)
is a Buy
Is Permian Resources a Buy, Sell or Hold?
-
The current Permian Resources [PR] share price is $15.48. The Score for PR is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
PR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $35.62. The Score for CRNX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PR Stock Price Chart
What is Permian Resources's stock price today?
-
The Permian Resources share price today is $15.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PR is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $35.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
PR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 65.01 | Buy |
Chaikin Money Flow: | 2339447 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.89 - 15.09) | Buy |
Bollinger Bands (100): | (13.62 - 15.08) | Buy |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.9 | Sell |
Relative Strength Index (14 RSI): | 18.28 | Sell |
Chaikin Money Flow: | -1800591 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.11 - 57.43) | Sell |
Bollinger Bands (100): | (50 - 58.12) | Sell |
PR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.12 | Buy |
20-day SMA: | 14.42 | Buy |
50-day SMA: | 14.77 | Buy |
200-day SMA: | 15.25 | Buy |
8-day EMA: | 15.06 | Buy |
20-day EMA: | 14.77 | Buy |
50-day EMA: | 14.66 | Buy |
200-day EMA: | 14.65 | Buy |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.04 | Sell |
20-day SMA: | 50.29 | Sell |
50-day SMA: | 54.55 | Sell |
200-day SMA: | 50.96 | Sell |
8-day EMA: | 44.02 | Sell |
20-day EMA: | 48.93 | Sell |
50-day EMA: | 52.43 | Sell |
200-day EMA: | 49.62 | Sell |
Permian Resources Earnings Growth & PR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.15 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Permian Resources Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |